Market revenue in 2020 | USD 7.8 billion |
Market revenue in 2028 | USD 28.1 billion |
Growth rate | 17.3% (CAGR from 2020 to 2028) |
Largest segment | Detection kits |
Fastest growing segment | Detection Kits |
Historical data | 2018 - 2019 |
Base year | 2020 |
Forecast period | 2021 - 2028 |
Quantitative units | Revenue in USD billion |
Market segmentation | Purification Kits, Amplification Kits, Detection Kits, Isolation Kits |
Key market players worldwide | Thermo Fisher Scientific Inc, Qiagen NV, New England Biolabs, Illumina Inc, Agilent Technologies Inc, Bio-Rad Laboratories Inc, Merck KGaA, Promega, Takara Bio Inc, LGC Group, Toyobo Co Ltd |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biotechnology reagents & kits market will help companies and investors design strategic landscapes.
Detection kits was the largest segment with a revenue share of 23.08% in 2020. Horizon Databook has segmented the Italy biotechnology reagents & kits market based on purification kits, amplification kits, detection kits, isolation kits covering the revenue growth of each sub-segment from 2018 to 2028.
In Italy, the biotechnology industry has witnessed rapid growth in the last few years, which is anticipated to continue in the near future. Many start-ups are focusing on the Italian market and have made efforts to enter this market.
In Italy, around 80% of the biotechnology industry is made up of small-sized companies, which is driving growth of the entire market. Nearly 50 new start-ups that are active in biotechnology were registered between 2017 and 2019, while 49% of biotech companies are continuously working in the health sector.
According to Assiobiotech, in the Italian biotech trade association, out of the 375 innovative therapies under development in 2020, 131 were in the discovery phase, 73 in the trial, and 171 in the pretrial process.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy biotechnology reagents & kits market , including forecasts for subscribers. This country databook contains high-level insights into Italy biotechnology reagents & kits market from 2018 to 2028, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account